Literature DB >> 3827959

Adult-onset Still's disease. Clinical course and outcome.

J J Cush, T A Medsger, W C Christy, D C Herbert, L A Cooperstein.   

Abstract

We reviewed the long-term natural history of 21 adult-onset Still's disease patients. Patient subsets were identified according to clinical course patterns. These included monocyclic systemic disease in 4, polycyclic systemic disease in 2, chronic articular monocyclic systemic disease in 10, and chronic articular polycyclic systemic disease in the remaining 5 patients. Functional outcome differed according to course patterns and the extent of articular involvement. Systemic manifestations, per se, did not contribute to poor functional prognosis. Chronic articular disease had the worst outcome: 27% evolved to functional class III status, compared with none in the cyclic systemic groups. Those patients who had a chronic articular pattern or a polyarticular onset and course were at higher risk to develop disabling arthritis. An aggressive approach to therapy, including the early use of remittive agents, should be considered in these patient subsets.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3827959     DOI: 10.1002/art.1780300209

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  80 in total

1.  Therapeutic responses and prognosis in adult-onset Still's disease.

Authors:  Hyoun-Ah Kim; Jun-Mo Sung; Chang-Hee Suh
Journal:  Rheumatol Int       Date:  2011-01-29       Impact factor: 2.631

2.  Tumour necrosis factor alpha blocking agents in refractory adult Still's disease: an observational study of 20 cases.

Authors:  B Fautrel; J Sibilia; X Mariette; B Combe
Journal:  Ann Rheum Dis       Date:  2004-06-07       Impact factor: 19.103

3.  Adult onset Still's disease: clinical features and course.

Authors:  D M Sánchez Loria; M J Moreno Alvarez; J A Maldonado Cocco; E J Scheines; O D Messina
Journal:  Clin Rheumatol       Date:  1992-12       Impact factor: 2.980

Review 4.  [Adult onset Still's disease, fever, diagnosis and therapy].

Authors:  N T Baerlecken; R E Schmidt
Journal:  Z Rheumatol       Date:  2012-04       Impact factor: 1.372

5.  The CD68(+)/H-ferritin(+) cells colonize the lymph nodes of the patients with adult onset Still's disease and are associated with increased extracellular level of H-ferritin in the same tissue: correlation with disease severity and implication for pathogenesis.

Authors:  P Ruscitti; F Ciccia; P Cipriani; G Guggino; P Di Benedetto; A Rizzo; V Liakouli; O Berardicurti; F Carubbi; G Triolo; R Giacomelli
Journal:  Clin Exp Immunol       Date:  2015-12-08       Impact factor: 4.330

6.  Acute respiratory failure revealing adult-onset Still's disease: diagnostic value of low glycosylated ferritin level.

Authors:  Charlotte Biron; Arnaud Chambellan; Christian Agard; Michele Denis; Patrick Germaud; Mohamed A Hamidou
Journal:  Clin Rheumatol       Date:  2005-11-10       Impact factor: 2.980

Review 7.  Diagnosis and management of adult onset Still's disease.

Authors:  P Efthimiou; P K Paik; L Bielory
Journal:  Ann Rheum Dis       Date:  2005-10-11       Impact factor: 19.103

8.  Prolonged remission in adult-onset Still's disease with etanercept.

Authors:  Rakesh Kumari; Sukhbir S Uppal
Journal:  Clin Rheumatol       Date:  2005-04-23       Impact factor: 2.980

9.  Long term evolution of adult onset Still's disease seen in an infectious diseases department.

Authors:  B Godeau; C Leport; C Perronne; D Salmon-Ceron; J L Vilde; M F Kahn
Journal:  Ann Rheum Dis       Date:  1991-12       Impact factor: 19.103

Review 10.  Molecular genetic analysis for periodic fever syndromes: a supplemental role for the diagnosis of adult-onset Still's disease.

Authors:  Hongbin Li; Irina Abramova; Sandra Chesoni; Qingping Yao
Journal:  Clin Rheumatol       Date:  2018-06-17       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.